KOD logo

KOD
Kodiak Sciences Inc

3,921
Mkt Cap
$2.27B
Volume
185,924.00
52W High
$47.84
52W Low
$3.26
PE Ratio
-8.68
KOD Fundamentals
Price
$36.60
Prev Close
$36.22
Open
$35.35
50D MA
$37.42
Beta
1.91
Avg. Volume
893,367.88
EPS (Annual)
-$4.32
P/B
20.08
Rev/Employee
$0.00
$1,437.02
Loading...
Loading...
News
all
press releases
Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally
Key PointsBoxer Capital added 225,000 shares of Kodiak Sciences; the estimated trade value was $5.81 million based on quarterly average prices...
Nasdaq News: Markets·4d ago
News Placeholder
More News
News Placeholder
This Pitney Bowes Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
Top analysts upgraded Starz Entertainment, Primoris Services, Pitney Bowes, Kodiak Sciences, and StandardAero. See what they think of PBI stock.read more...
Benzinga·10d ago
News Placeholder
Kodiak's Q1 Loss Wider Than Expected, Pipeline Development in Focus
KOD posts a wider Q1 loss as research & development spending rises, while positive phase III Zenkuda data accelerate the regulatory plans.
Zacks·13d ago
News Placeholder
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results PR Newswire...
PR Newswire·14d ago
News Placeholder
Kodiak Sciences Inc. $KOD Stock Holdings Decreased by RIA Advisory Group LLC
RIA Advisory Group LLC reduced its position in Kodiak Sciences Inc. (NASDAQ:KOD - Free Report) by 31.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 113,473 shares of the company's...
MarketBeat·18d ago
News Placeholder
Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences
Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a...
PR Newswire·21d ago
News Placeholder
Kodiak Sciences (KOD) Up 2% Since Last Earnings Report: Can It Continue?
Kodiak Sciences (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·21d ago
News Placeholder
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of Kodiak Sciences Inc. (NASDAQ:KOD - Get Free Report) have received an average recommendation of "Moderate Buy" from the eight research firms that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have gi...
MarketBeat·1mo ago
News Placeholder
Kodiak Sciences (NASDAQ:KOD) Hits New 12-Month High - What's Next?
Kodiak Sciences (NASDAQ:KOD) Hits New 1-Year High - Here's Why...
MarketBeat·1mo ago
News Placeholder
Kodiak Sciences (NASDAQ:KOD) Stock Price Up 9.8% - What's Next?
Kodiak Sciences (NASDAQ:KOD) Trading 9.8% Higher - Here's What Happened...
MarketBeat·1mo ago
<
1
2
...
>

Latest KOD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.